Barchart.com
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | More
 
or
Watchlist | Portfolio
Site News
Contact
Market:

Venus Concept Inc (VERO)

Venus Concept Inc (VERO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
ReWalk Robotics (RWLK) Reports Q2 Loss, Misses Revenue Estimates Zacks - Tue Aug 9, 2022

ReWalk (RWLK) delivered earnings and revenue surprises of -75% and 32.33%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

RWLK : 1.0501 (+6.07%)
VERO : 0.6800 (-11.56%)
Glaukos (GKOS) Reports Q2 Loss, Tops Revenue Estimates Zacks - Wed Aug 3, 2022

Glaukos (GKOS) delivered earnings and revenue surprises of -88.64% and 7.51%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

GKOS : 99.49 (-0.62%)
VERO : 0.6800 (-11.56%)
Venus Concept to Release Second Quarter of Fiscal Year 2022 Financial Results on August 12, 2022 Globe Newswire - Thu Jun 30, 2022

TORONTO, June 30, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.6800 (-11.56%)
Venus Concept (VERO) Reports Q1 Loss, Misses Revenue Estimates Zacks - Thu May 12, 2022

Venus Concept (VERO) delivered earnings and revenue surprises of -30% and 2.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

VERO : 0.6800 (-11.56%)
AXDX : 0.9300 (-1.62%)
Venus Concept Announces First Quarter of Fiscal Year 2022 Financial Results; Reaffirms Fiscal Year 2022 Revenue Guidance Globe Newswire - Thu May 12, 2022

TORONTO, May 12, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.6800 (-11.56%)
Globus Medical (GMED) Misses Q1 Earnings and Revenue Estimates Zacks - Tue May 10, 2022

Globus Medical (GMED) delivered earnings and revenue surprises of -8.70% and 1.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

GMED : 50.68 (+0.62%)
VERO : 0.6800 (-11.56%)
Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates Zacks - Thu May 5, 2022

Alphatec (ATEC) delivered earnings and revenue surprises of -48.28% and 4.74%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ATEC : 12.48 (+1.96%)
VERO : 0.6800 (-11.56%)
Venus Concept Receives New FDA 510(k) Clearance for Venus BlissMAX Globe Newswire - Thu Apr 28, 2022

Clearance Expands Indications for Use to Include Non-Invasive Lipolysis of the Back and Thighs and Increases Maximum Energy Output to 150 Watts...

VERO : 0.6800 (-11.56%)
Venus Concept Announces First Patient Treatment in Study Evaluating the Safety and Efficacy of Aime™ Next Generation Robotic Technology for the Treatment of Moderate to Severe Facial Wrinkles Globe Newswire - Mon Apr 25, 2022

TORONTO, April 25, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.6800 (-11.56%)
Venus Concept to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022 Globe Newswire - Mon Apr 4, 2022

TORONTO, April 04, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.6800 (-11.56%)

Barchart Exclusives

Microsoft Shows Massive FCF Growth Despite High AI Spending - MSFT Looks Undervalued Barchart - Fri Apr 26, 9:51AM CDT
Microsoft produced excellent quarterly results with higher free cash flow despite increased AI capex spending. This makes MSFT look undervalued here and provides a good opportunity for short-put investors. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar

[[ data.userDate ]]
[[ data.eventTime | date: 'EEE, MMM dd, yyyy h:mm a' ]] [[ zone ]]
Reserve Your Spot